| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/22/2011 | US20110230418 Anticancer Agent |
| 09/22/2011 | US20110230417 Treatment of diseases and conditions mediated by increased phosphorylation |
| 09/22/2011 | US20110230416 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates |
| 09/22/2011 | US20110230415 Pharmaceutical Composition Containing GHRP-6 To Prevent And Eliminate Fibrosis And Other Pathological Deposits In Tissues |
| 09/22/2011 | US20110230414 Pyrrolopyrazine Kinase Inhibitors |
| 09/22/2011 | US20110230413 Predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis |
| 09/22/2011 | US20110230412 Neuregulin Peptides And Their Use |
| 09/22/2011 | US20110230411 Albumin fibers and fabrics and methods of generating and using same |
| 09/22/2011 | US20110230410 LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY |
| 09/22/2011 | US20110230409 GLP-I Agonist And Cardiovascular Complications |
| 09/22/2011 | US20110230408 Human growth hormone aqueous formulation |
| 09/22/2011 | US20110230407 Hepatocyte growth factor pathway activators in demyelinating diseases and central nervous system trauma |
| 09/22/2011 | US20110230406 Affinity peptides toward bmp-2 |
| 09/22/2011 | US20110230405 Peptides and Supported Peptides for Treating Skin Diseases |
| 09/22/2011 | US20110230404 Glycoproteins Produced in Plants and Methods of Their Use |
| 09/22/2011 | US20110230403 Glycoside derivatives and uses thereof |
| 09/22/2011 | US20110230402 Treating diabetes melitus using insulin injections with less than daily injection frequency |
| 09/22/2011 | US20110230401 Insulin fusion polypeptides |
| 09/22/2011 | US20110230400 Nutritional composition for wound healing |
| 09/22/2011 | US20110230399 Methods for Treating Obesity Related Disease |
| 09/22/2011 | US20110230398 Apolipoprotein C-II or its active fractions for the prevention or treatment of obesity and related metabolic disorders |
| 09/22/2011 | US20110230397 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer |
| 09/22/2011 | US20110230396 Anti-infective compounds and uses thereof |
| 09/22/2011 | US20110230393 Antibacterial Phage Peptides and Methods of Use thereof |
| 09/22/2011 | US20110230392 Novel narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, and narc 25 molecules and uses therefor |
| 09/22/2011 | US20110230391 Fc gamma receptor for the treatment of b cell mediated multiple sclerosis |
| 09/22/2011 | US20110229944 FAD4, FAD5, FAD5-2, AND FAD6, Novel Fatty Acid Desaturase Family Members and Uses Thereof |
| 09/22/2011 | US20110229890 Egfr mutations |
| 09/22/2011 | US20110229598 Enhanced lactoperoxidase system for treatment of milk products |
| 09/22/2011 | US20110229585 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 09/22/2011 | US20110229581 Releasable cationic lipids for nucleic acids delivery systems |
| 09/22/2011 | US20110229568 Michael systems as transglutaminase inhibitors |
| 09/22/2011 | US20110229565 Drug Delivery Composition Comprising a Self-Assembled Gelator |
| 09/22/2011 | US20110229560 Nlrc5 as a target for immune therapy |
| 09/22/2011 | US20110229554 INTRAVENOUS FORMULATIONS OF COENZYME Q10 (CoQ10) AND METHODS OF USE THEREOF |
| 09/22/2011 | US20110229551 Drug delivery compositions and methods using nanofiber webs |
| 09/22/2011 | US20110229550 Acid-Degradable and Bioerodible Modified Polyhydroxylated Materials |
| 09/22/2011 | US20110229547 Process for producing inorganic interconnected 3d open cell bone substitutes |
| 09/22/2011 | US20110229546 Treatment of dissection, aneurysm, and atherosclerosis using granzyme b inhibitors |
| 09/22/2011 | US20110229528 Pegylated polyplexes for polynucleotide delivery |
| 09/22/2011 | US20110229525 Modulation of cytokine signaling |
| 09/22/2011 | US20110229524 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of Gastric Cancer and other cancers |
| 09/22/2011 | US20110229521 Nutritional support of the immune system during anti-cancer treatment |
| 09/22/2011 | US20110229515 Identification of genes |
| 09/22/2011 | US20110229505 Methods for the diagnosis and treatment of cancer based on AVL9 |
| 09/22/2011 | US20110229499 Method for treatment of vascular hyperpermeability |
| 09/22/2011 | US20110229495 Methods for predicting development of auto-immune diseases and treatment of same |
| 09/22/2011 | US20110229492 Compositions and methods for diagnosing, treating, and preventing prostate conditions |
| 09/22/2011 | US20110229491 Minichromosome maintenance complex interacting protein involved in cancer |
| 09/22/2011 | US20110229485 Inhibition of the nt-3:trkc bound and its application to the treatment of cancer such as neuroblastoma |
| 09/22/2011 | US20110229483 Tumor angiogenesis associated genes and a method for their identification |
| 09/22/2011 | US20110229482 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood by preventing viral entry into a cell |
| 09/22/2011 | US20110229481 Cancer-associated antigen analogue peptides and uses thereof |
| 09/22/2011 | US20110229478 Erbb3 based methods and compositions for treating neoplasms |
| 09/22/2011 | US20110229477 Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy |
| 09/22/2011 | US20110229473 Methods for using taci-immunoglobulin fusion proteins |
| 09/22/2011 | US20110229472 Peptides and Related Compounds Having Thrombopoietic Activity |
| 09/22/2011 | US20110229466 Vascular endothelial growth factor 2 |
| 09/22/2011 | US20110229465 Composition for treating disease |
| 09/22/2011 | US20110229458 Methods for selecting protease resistant polypeptides |
| 09/22/2011 | US20110229457 Injectable drug delivery system |
| 09/22/2011 | US20110229456 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 09/22/2011 | US20110229455 Stabilized liquid and lyophilized adamts13 formulations |
| 09/22/2011 | US20110229454 Use of Prourokinase and Variants Thereof in Facilitated Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction |
| 09/22/2011 | US20110229453 Blood coagulation factor inhibitors |
| 09/22/2011 | US20110229452 Ophthalmic Surgical Irrigating Solutions Containing Hyaluronidase |
| 09/22/2011 | US20110229451 Temperature sensitive mutants of matrix metalloproteases and uses thereof |
| 09/22/2011 | US20110229450 Enzymes and methods for degrading s-triazines and diazines |
| 09/22/2011 | US20110229449 Prophylaxis and treatment of macular degeneration and retinopathy using a prdx protein |
| 09/22/2011 | US20110229447 Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment |
| 09/22/2011 | US20110229444 Neuregulin And Cardiac Stem Cells |
| 09/22/2011 | US20110229439 Complement proteins |
| 09/22/2011 | US20110229438 Method of inhibiting hepatitus c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds |
| 09/22/2011 | US20110229437 Method of Treating Asthma with Antiviral Agents |
| 09/22/2011 | US20110229436 Methods for reducing the likelihood of spontaneous abortion during assisted reproduction in a subject |
| 09/22/2011 | US20110229435 Expression and purification of hip/pap and uses therefor |
| 09/22/2011 | US20110229434 Uses of mammalian cytokine; related reagents |
| 09/22/2011 | US20110229433 Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection |
| 09/22/2011 | US20110229411 Use of p2x7 pathway for assessing the sensitivity of a subject to a cancer treatment |
| 09/22/2011 | US20110229409 Linkable lewis x analogs |
| 09/22/2011 | US20110229407 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof |
| 09/22/2011 | DE102010012199A1 Molekular geprägte Polymere für die Eliminierung von Metaboliten Molecularly imprinted polymers for the elimination of metabolites |
| 09/22/2011 | CA2793838A1 Integrin interaction inhibitors for the treatment of cancer |
| 09/22/2011 | CA2793686A1 Pharmaceutical compositions comprising a pancreatic enzyme preparation with viral infectivity reduced below a significant level and methods of preparing and using the same |
| 09/22/2011 | CA2793685A1 Gastro-resistant enzyme pharmaceutical compositions |
| 09/22/2011 | CA2793671A1 Bmp-2 peptides & methods of use |
| 09/22/2011 | CA2793465A1 Tfpi inhibitors and methods of use |
| 09/22/2011 | CA2792927A1 Proteoglycan-containing microneedle array |
| 09/22/2011 | CA2792866A1 Pharmaceutical compositions of growth hormone secretagogue receptor ligands |
| 09/22/2011 | CA2792749A1 Composition for nasal administration and method for preparing it |
| 09/22/2011 | CA2789857A1 Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| 09/21/2011 | EP2367008A2 Modulating the interaction betwenn HGF beta chain and C-Met |
| 09/21/2011 | EP2366787A2 Codon optimized IL-15 and IL-15R-Alpha genes for expression in mammalian cells |
| 09/21/2011 | EP2366717A2 Combination Cancer Immunotherapy with Co-Stimulatory Molecules |
| 09/21/2011 | EP2366713A2 Polypeptide variants with altered effector function |
| 09/21/2011 | EP2366712A2 A tumor suppressor designated TS10Q23.3 |
| 09/21/2011 | EP2366711A2 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer |
| 09/21/2011 | EP2366707A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 09/21/2011 | EP2366706A1 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 09/21/2011 | EP2366705A1 Methods for synthesis of encoded libraries |